Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Genetic Basis, Expression Patterns and Clinical Significance of PD-L1 in Peripheral T-Cell Lymphomas (PTCL)

Pedro Farrajota Neves Da Silva, MD, Vassilis Atsaves, PhD, Nikolaos Tsesmetzis, MSc., Georgia Kokaraki, PhD, Anders Österborg, MD PhD Prof., George Rassidakis, MD PhD

Blood (2018) 132 (Supplement 1): 2868.

https://doi.org/10.1182/blood-2018-99-120036

Published: 2018

Journal Articles

The Novel Tumor Suppressor SAMHD1 Is Differentially Expressed and Partly Regulated By MYC in Peripheral T-Cell Lymphomas (PTCL)

Pedro Farrajota Neves Da Silva, MD, Nikolaos Tsesmetzis, Ioanna Xagoraris, MD, Agata Magdalena Wasik, PhD MSc, Georgia Kokaraki, PhD, Evangelos Tzoras, Anders Österborg, MD PhD Prof., Birgitta Sander, MD PhD, Nikolas Herold, MD PhD, George Rassidakis, MD PhD

Blood (2018) 132 (Supplement 1): 4130.

https://doi.org/10.1182/blood-2018-99-119229

Published: 2018

Journal Articles

SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival

Agata Magdalena Wasik, PhD MSc, Elin Marin, MD, Magali Merrien, MSc, Joana de Matos Rodrigues, PhDstudent, Martin Lord, PhD, Ioanna Xagoraris, MD, Birger Christensson, MD PhD, George Rassidakis, MD PhD, Mats Jerkeman, Sara Ek, PhD, Birgitta Sander, MD PhD

Blood (2018) 132 (Supplement 1): 4136.

https://doi.org/10.1182/blood-2018-99-118087

Published: 2018

Journal Articles

PD-L1 Expression and Gene Amplification in CD30+ Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics

George Rassidakis, MD PhD, Yi Miao, MD PhD, Jun Zhang, MD, Vassilis Atsaves, PhD, Lorand Kis, MD PhD, Karin E Smedby, MD PhD, Yong Li, PhD, Zijun Yidan Xu-Monette, PhD, Ken H. Young, MD PhD

Blood (2017) 130 (Supplement 1): 1475.

https://doi.org/10.1182/blood.V130.Suppl_1.1475.1475

Published: 2017

Journal Articles

Downregulation of the Tumor Suppressor SAMHD1 in Classical Hodgkin Lymphoma

Ioanna Xagoraris, MD, Theodoros Vassilakopoulos, MDPhD, Nikolas Herold, MDPhD, Nikolaos Tsesmetzis, MSc., Elias Drakos, MD PhD, Joseph David Khoury, MD, George Rassidakis, MD PhD

Blood (2017) 130 (Supplement 1): 1480.

https://doi.org/10.1182/blood.V130.Suppl_1.1480.1480

Published: 2017

Journal Articles

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Blood (2017) 130 (Supplement 1): 197.

https://doi.org/10.1182/blood.V130.Suppl_1.197.197

Published: 2017

Journal Articles

MAPKAP1 (Sin1), a Key Component of the MTORC2 Complex, Confers Resistance to Sorafenib and Correlates with Adverse Clinical Outcomes in Acute Myeloid Leukemia

Joseph David Khoury, MD, Ioanna Xagoraris, MD, Nikolaos Tsesmetzis, MSc., Ida Hed Hed Myrberg, PhD, Thale Kristin Olsen, Siok Bian Ng, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Benedict Yan, Chin Hin Ng, MD MRCP, Michael Andreeff, MD PhD, L. Jeffrey Medeiros, MD, Hagop M. Kantarjian, MD, Herold Nikolas, MD PhD, Dan Grander, MD PhD, George Rassidakis, MD PhD

Blood (2017) 130 (Supplement 1): 3964.

https://doi.org/10.1182/blood.V130.Suppl_1.3964.3964

Published: 2017

Journal Articles

Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens

George Rassidakis, MD PhD, Herold Nikolas, MD PhD, Ida Hed Hed Myrberg, PhD, Nikolaos Tsesmetzis, MSc., Dan Grander, MD PhD, Hagop M. Kantarjian, MD, L. Jeffrey Medeiros, MD, Ioanna Xagoraris, MD, Joseph David Khoury, MD

Blood (2017) 130 (Supplement 1): 3928.

https://doi.org/10.1182/blood.V130.Suppl_1.3928.3928

Published: 2017

Journal Articles

Lower Levels of Survivin in Patients with Leukemic Low Grade B-Cell Lymphomas Expressing LMP1 Oncoprotein of Epstein-Barr Virus

Panagiotis Theodorou Diamantopoulos, Katerina Polonyphi, Maria Sofotasioiu, Athanassios Galanopoulos, Nikolaos Spanakis, George Rassidakis, MD, PhD, Panagiotis Kouzis, Vassiliki Papadopoulou, Fani Kalala, Theodoros Iliakis, Theodoros Vassilakopoulos, Maria K. Angelopoulou, Marina Siakantaris, M.D., Evangelos Terpos, Eleni Variami, Panagoula Kollia, Gerassimos A Pangalis, Nora-Athina Viniou

Blood (2012) 120 (21): 1560.

https://doi.org/10.1182/blood.V120.21.1560.1560

Published: 2012

Journal Articles

CD4(+)/CD56(+) Hematodermic (plasmacytoid dendritic cell) Tumor: a Highly Proliferating Neoplasm with Aberrant Expression of Immunohistochemical Markers and Poor Outcome.

Marina Siakantaris, M.D., George Rassidakis, MD, PhD, Flora Kontopidou, MD, Aglaia Dimitrakopoulou, MD, Theodoros Vassilakopoulos, MD, Maria K. Angelopoulou, Styliani Kokkoris, MD, Nikolaos Evangelatos, MD, Konstantinos Anargyrou, MD, Othon Michail, MD, Penelope Korkolopoulou, MD, G.A. Pangalis

Blood (2009) 114 (22): 2930.

https://doi.org/10.1182/blood.V114.22.2930.2930

Published: 2009

Journal Articles

A Biologically Distinctive Subgroup of Acute Myelogenous Leukemia with Characteristic Nuclear Morphology and a High Frequency of FLT3 Mutation.

Weina Chen, MD, PhD, George Rassidakis, MD, PhD, Mark Routbort, MD, Dan Jones, MD, PhD, L. Jeffrey Medeiros, MD, Carlos Bueso-Ramos, MD, PhD

Blood (2005) 106 (11): 4522.

https://doi.org/10.1182/blood.V106.11.4522.4522

Published: 2005

NARROW

Genetic Basis, Expression Patterns and Clinical Significance of PD-L1 in Peripheral T-Cell Lymphomas (PTCL)

The Novel Tumor Suppressor SAMHD1 Is Differentially Expressed and Partly Regulated By MYC in Peripheral T-Cell Lymphomas (PTCL)

SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival

PD-L1 Expression and Gene Amplification in CD30+ Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics

Downregulation of the Tumor Suppressor SAMHD1 in Classical Hodgkin Lymphoma

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

MAPKAP1 (Sin1), a Key Component of the MTORC2 Complex, Confers Resistance to Sorafenib and Correlates with Adverse Clinical Outcomes in Acute Myeloid Leukemia

Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens

Lower Levels of Survivin in Patients with Leukemic Low Grade B-Cell Lymphomas Expressing LMP1 Oncoprotein of Epstein-Barr Virus

CD4(+)/CD56(+) Hematodermic (plasmacytoid dendritic cell) Tumor: a Highly Proliferating Neoplasm with Aberrant Expression of Immunohistochemical Markers and Poor Outcome.

A Biologically Distinctive Subgroup of Acute Myelogenous Leukemia with Characteristic Nuclear Morphology and a High Frequency of FLT3 Mutation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only